Key result
Free-breathing 3D T1ρ mapping at 0.55T shows promise for non-contrast whole-heart tissue characterization.
Why the study?
Experience with cardiac T1ρ mapping at low-field strength 0.55T remains limited, necessitating development and validation of efficient non-contrast whole-heart tissue characterization methods.
Does a free-breathing 3D adiabatic T1ρ mapping sequence provide accurate and precise non-contrast whole-heart tissue characterization at 0.55T compared to 2D sequences in healthy volunteers?
Does a free-breathing 3D adiabatic T1ρ mapping sequence provide accurate and precise non-contrast whole-heart tissue characterization at 0.55T compared to 2D sequences in healthy volunteers?
Absolute Event Rate: 112.8% vs 106.1%
p-value: p=<0.01
A novel free-breathing 3D adiabatic T1ρ mapping sequence at 0.55T MRI is feasible and provides accurate whole-heart tissue characterization in a clinically acceptable scan time.
May enable non-contrast low-field cardiac MRI; hypothesis-generating pending clinical validation.
BACKGROUND: Commercial 0.55T low-field magnetic resonance imaging (MRI) systems have recently become available, offering the potential to enhance global accessibility to MRI. T1ρ mapping is an emerging quantitative cardiac MR imaging technique capable of detecting myocardial disease without the need for contrast administration. However, experience with cardiac T1ρ mapping at low-field strength remains limited. This study aims to develop and validate an efficient, free-breathing three-dimensional (3D) high-resolution adiabatic T1ρ mapping sequence for non-contrast whole-heart tissue characterization at 0.55T. METHODS: The proposed 3D T1ρ mapping research sequence acquires four interleaved volumes with different contrast weightings using saturation and adiabatic spin-lock preparation pulses, and a 3-parameter fitting method is used to calculate T1ρ maps. Two-dimensional (2D) image navigators are acquired for non-rigid motion-compensated image reconstruction, enabling 100% respiratory scan efficiency. Phantom and in-vivo experiments in 10 healthy volunteers were conducted to evaluate the accuracy and precision of the proposed 3D sequence in comparison with 2D T1ρ mapping sequences. RESULTS: = 0.997), demonstrating high accuracy and reduced sensitivity to heart rate variations. In-vivo experiments in healthy subjects demonstrated that the proposed sequence is feasible for acquiring whole-heart T1ρ maps with 2 mm isotropic resolution in an efficient scan time of 6.6±0.5 min. The mean myocardial T1ρ value obtained with the 3D sequence was slightly higher than that of a conventional 2D breath-hold sequence (112.8±16.7 vs. 106.1±15.1%, p<0.01), while coefficient of variation (CV) was slightly lower (10.2±5.2 vs. 11.4±4.4%, p = 0.02). CONCLUSION: The proposed sequence enables 3D free-breathing high-resolution adiabatic T1ρ mapping and shows promising potential for non-contrast whole-heart tissue characterization at 0.55T.
No takes yet. Share an insight, caveat, or question.
Si et al. (2025) studied Healthy volunteers (n=10). 3D free-breathing high-resolution adiabatic T1ρ mapping sequence vs. Conventional 2D breath-hold sequence was evaluated on Mean myocardial T1ρ value (p=<0.01). The 3D free-breathing T1ρ mapping sequence yielded slightly higher mean myocardial T1ρ values than a conventional 2D breath-hold sequence (112.8±16.7 vs. 106.1±15.1%, p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: